The best of Business Standard for you
Get the best of our journalism, and complimentary access to The New York Times
Subscribe NowUpdated On : 25 Jun 2026 | 00:27 am IST
Biocon, Zydus, Dr Reddy's are among companies positioning for one of the largest biosimilar launches for cancer treatment
Business Standard subscribers get complimentary access to The New York Timesincluding News, Games, Cooking, Audio, Wirecutter & The AthleticsSubscribe Now

Updated On : Invalid Date IST
Read 30+ premium stories, hand-picked by our editors every day
Subscribe Now
Curated newsletters on markets, personal finance, politics, tech, and more in your inbox
Subscribe Now
Updated On : Invalid Date IST
Unlock Ad-free reading on all devicesSubscribe Now
